The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 19 , ISSUE 2 ( February, 2018 ) > List of Articles


Estimation of Plasma Levels of Tumor Necrosis Factor-α, Interleukin-4 and 6 in Patients with Chronic Periodontitis and Type II Diabetes Mellitus

Jasjit Sahota, Dipanshu Bakshi, Guneet Kaur, Deepinder Singh, Ambika Thakur, Shekhar Grover

Citation Information : Sahota J, Bakshi D, Kaur G, Singh D, Thakur A, Grover S. Estimation of Plasma Levels of Tumor Necrosis Factor-α, Interleukin-4 and 6 in Patients with Chronic Periodontitis and Type II Diabetes Mellitus. J Contemp Dent Pract 2018; 19 (2):166-169.

DOI: 10.5005/jp-journals-10024-2231

License: CC BY 3.0

Published Online: 01-08-2012

Copyright Statement:  Copyright © 2018; The Author(s).



Both periodontitis and type II diabetes mellitus (T2DM) are common diseases with a multifactorial etiology and have influence of cytokines in their pathogenesis and thus may also influence each other. In recent times, more attention has been given to understanding the influences of these inflammatory cytokines which are a main part of oral chronic inflammation on systemic health of the individuals. Therefore, the aim of this study was to evaluate the plasma cytokine levels, specifically tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-4, in chronic periodontitis patients and T2DM patients, so as to investigate the influence of chronic periodontitis in systemic inflammation associated with diabetes mellitus.

Materials and methods

The present study comprised a total sample size of 60 patients. A detailed history along with complete periodontal examination were done for each person. These patients were subdivided into four study groups with 15 subjects (n = 15) in each group: group I: healthy individuals, group II: chronic periodontitis, group III: diabetes mellitus without chronic periodontitis, and group IV: diabetes mellitus with chronic periodontitis. Venous blood was withdrawn for obtaining serum samples from the subjects. Hemoglobin A1c (HbA1c) levels were measured from the automated chromatography. Using enzyme-linked immunosorbent assay kit, TNF-α, IL-4, and IL-6 were measured.


It was observed that the difference between almost all the results showed statistical significance. Not much of a difference was seen when TNF-α and IL-6 findings of group II were compared with group III. Furthermore, IL-4 also did not differ when group II was compared with group IV.


The inflammatory cytokines together control the inflammation process and a balance is maintained. However, in patients with diabetes mellitus, this balance is interrupted, which affects the final development and progression of the disease. Thus, hyperglycemia may be partly associated with the severity of the periodontal status in diabetic patients.

Clinical significance

Hyperglycemia thus may play a role in increasing the severity of the periodontal status in diabetic patients. Keeping such relationship in mind, better treatment modalities can be provided to the patients.

How to cite this article

Bakshi D, Kaur G, Singh D, Sahota J, Thakur A, Grover S. Estimation of Plasma Levels of Tumor Necrosis Factor-α, Interleukin-4 and 6 in Patients with Chronic Periodontitis and Type II Diabetes Mellitus. J Contemp Dent Pract 2018;19(2):166-169.

  1. Carranzas clinical periodontology. 10th ed. St Louis: Elsevier Health Sciences; 2006.
  2. Innate cellular responses to the periodontal biofilm. Front Oral Biol 2012;15:41-55.
  3. Periodontitis: oral complication of diabetes. Endocrinol Metab Clin North Am 2013 Dec;42(4):849-867.
  4. TNF trafficking to human mast cell granules: Mature chain-dependent endocytosis. J Immunol 2007 May;178(9):5701-5709.
  5. A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J Periodontal Res 2010 Feb;45(1):148-152.
  6. Periodontitis and diabetes interrelationships: role of inflammation. Ann Periodontol 2001 Dec;6(1):125-137.
  7. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003 Mar;74(3):391-401.
  8. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
  9. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997 Dec;82(12):4196-4200.
  10. Changes in gingival crevicular fluid interleukin-4 and interferon-gamma in patients with chronic periodontitis before and after periodontal initial therapy. Kaohsiung J Med Sci 2007 Jan;23(1):1-7.
  11. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012 Jan;55(1):21-31.
  12. Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis. J Clin Periodontol 2009;36:922-927.
  13. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. J Clin Periodontol 2010 Jun;37(6):487-493.
  14. Salivary type I collagen degradation end-products and related matrix in periodontitis. J Clin Periodontol 2013 Jan;40(1):18-25.
  15. Tumor necrosis factor-α, interleukin-4 and-6 in the serum of health, chronic periodontitis, and type 2 diabetes mellitus. J Indian Soc Periodontol 2016;20(5):509-513.
  16. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol 2013 Apr;40 (Suppl 14):S113-S134.
  17. Role of serum cytokines tumour necrosis factor-alpha and interleukin-6 in the association between body weight and periodontal infection. J Clin Periodontol 2009 Feb;36(2):100-105.
  18. Cytokines and bone-related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis. J Periodontol 2011 Aug;82(8):1187-1196.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.